Sign In
Buy TRINI
Trinity Capital . 7.875% Notes Due 2029 Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | $0.520 |
| EPS actual | $0.530 |
| EPS Surprise | 1.92% |
| Revenue estimate | 85.89M |
| Revenue actual | 83.319M |
| Revenue Surprise | -2.99% |
| Release date | Feb 25, 2026 |
| EPS estimate | $0.516 |
| EPS actual | $0.520 |
| EPS Surprise | 0.775% |
| Revenue estimate | 80.279M |
| Revenue actual | 83.235M |
| Revenue Surprise | 3.68% |
| Release date | Nov 05, 2025 |
| EPS estimate | - |
| EPS actual | $0.526 |
| Revenue estimate | - |
| Revenue actual | 72.575M |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.519 |
| EPS actual | $0.628 |
| EPS Surprise | 21.00% |
| Revenue estimate | 69.102M |
| Revenue actual | 66.713M |
| Revenue Surprise | -3.46% |
Last 4 Quarters for Trinity Capital . 7.875% Notes Due 2029
Below you can see how TRINI performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $25.41 |
| EPS estimate | $0.519 |
| EPS actual | $0.628 |
| EPS surprise | 21.00% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $25.39 |
| Aug 01, 2025 | $25.34 |
| Aug 04, 2025 | $25.30 |
| Aug 05, 2025 | $25.45 |
| Aug 06, 2025 | $25.41 |
| Aug 07, 2025 | $25.46 |
| Aug 08, 2025 | $25.45 |
| Aug 11, 2025 | $25.51 |
| Aug 12, 2025 | $25.52 |
| 4 days before | 0.0591% |
| 4 days after | 0.453% |
| On release day | 0.216% |
| Change in period | 0.512% |
| Release date | Nov 05, 2025 |
| Price on release | $25.59 |
| EPS estimate | - |
| EPS actual | $0.526 |
| Date | Price |
|---|---|
| Oct 30, 2025 | $25.46 |
| Oct 31, 2025 | $25.41 |
| Nov 03, 2025 | $25.58 |
| Nov 04, 2025 | $25.57 |
| Nov 05, 2025 | $25.59 |
| Nov 06, 2025 | $25.57 |
| Nov 07, 2025 | $25.59 |
| Nov 10, 2025 | $25.59 |
| Nov 11, 2025 | $25.56 |
| 4 days before | 0.525% |
| 4 days after | -0.130% |
| On release day | -0.0910% |
| Change in period | 0.394% |
| Release date | Feb 25, 2026 |
| Price on release | $25.47 |
| EPS estimate | $0.516 |
| EPS actual | $0.520 |
| EPS surprise | 0.775% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $25.51 |
| Feb 20, 2026 | $25.51 |
| Feb 23, 2026 | $25.52 |
| Feb 24, 2026 | $25.52 |
| Feb 25, 2026 | $25.47 |
| Feb 26, 2026 | $25.50 |
| Feb 27, 2026 | $25.53 |
| Mar 02, 2026 | $25.47 |
| Mar 03, 2026 | $25.47 |
| 4 days before | -0.157% |
| 4 days after | 0% |
| On release day | 0.118% |
| Change in period | -0.157% |
| Release date | May 06, 2026 |
| Price on release | $25.36 |
| EPS estimate | $0.520 |
| EPS actual | $0.530 |
| EPS surprise | 1.92% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $25.34 |
| May 01, 2026 | $25.34 |
| May 04, 2026 | $25.34 |
| May 05, 2026 | $25.33 |
| May 06, 2026 | $25.36 |
| May 07, 2026 | $25.39 |
| May 08, 2026 | $25.41 |
| May 11, 2026 | $25.42 |
| May 12, 2026 | $25.40 |
| 4 days before | 0.0793% |
| 4 days after | 0.158% |
| On release day | 0.118% |
| Change in period | 0.237% |
Trinity Capital . 7.875% Notes Due 2029 Earnings Call Transcript Summary of Q1 2026
Key investor takeaways:
- Strong growth and financials: NAV reached a record $1.2 billion (up 7% QoQ, 40% YoY); platform AUM > $2.9 billion (up 36% YoY). Q1 net investment income (NII) was $44.5M, $0.53 per share, covering 104% of the quarterly distribution. Return on average equity was 15.8% in Q1.
- Managed-funds strategy driving diversification and fee income: Managed funds AUM is $400M across four vehicles; managed-funds income contributed ~$0.04/sh to Q1 NII. Initial close of $45.3M equity to a new SBIC fund (target $87.5M) with SBA license approved; SBIC expected to add ~ $260M of incremental capacity when scaled.
- Capital strategy and new JV: Entered a joint venture with Capital Southwest to access first-out senior secured loans in the lower middle market (50/50 governance). Raised $78.4M through ATM at an average premium to NAV of 12% in Q1. Net leverage ~1.15x and platform liquidity > $500M (including managed-funds capacity).
- Credit and portfolio quality: Nonaccruals ~1% of the portfolio at fair value; ~99% of debt investments performing at fair value. 88% of principal secured by first-position liens; weighted average loan-to-value on enterprise-backed loans ~19%. Portfolio diversified across 22 industries; no single borrower >4% exposure.
- Originations and pipeline: Q1 funded $306M (39% above 2025 Q1) with $396M of commitments; unfunded commitments ~$1.2B (94% conditional subject to diligence/approval). Fundings mix: 41% life sciences, 22% equipment finance, 13% sponsor finance, 13% tech lending, 11% asset-backed lending.
- Dividend and shareholder focus: Paying $0.17 monthly dividend through end of Q2; scheduled to announce Q3 dividend in June (subject to board approval). Estimated undistributed taxable income ~ $68M (~$0.78/sh), ~4+ months of distributions.
- Risk/valuation notes: Q1 included ~$10M net realized losses and ~$5M net unrealized depreciation (driven by equity conversions and mark-to-market). NAV per share moved from $13.42 to $13.27 (down QoQ, but +2% YoY). PIK is immaterial (~1% of income). About 60% of portfolio at cost originated since start of 2025, showing recent vintages skew.
- Strategic posture: Management emphasizes disciplined underwriting, diversified five-vertical platform, internal management alignment (management/employees own same shares as investors), and a stated priority to grow fee-bearing off-balance-sheet vehicles to add income while limiting dilution to public shareholders.
